Skip to content
Remdesivir - A new open-label trial episode artwork

Aug 24, 2020 9 min

Remdesivir - A new open-label trial

from FOAMcast - An Emergency Medicine Podcast

We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear* We review Spinner et al in JAMA 2020, an open label trial of remdesivir 5 days vs remdesivir 10 days vs 'standard of care' for the treatment of #COVID19 Show notes: FOAMcast.org Thanks for listening, Lauren Westafer and Jeremy Faust

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Remdesivir - A new open-label trial

0:00 9:58

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of FOAMcast - An Emergency Medicine Podcast?

This episode is 9 minutes long.

When was this FOAMcast - An Emergency Medicine Podcast episode published?

This episode was published on August 24, 2020.

Can I download this FOAMcast - An Emergency Medicine Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.